1.
Evolving Regulatory Positions and Legacy Data Challenges: A Case Study of Fludioxonil’s Unknown Metabolite Fraction MF2 in European Active Ingredient Renewal. AJEER [Internet]. 2025 Oct. 3 [cited 2026 Feb. 6];1(1):1-7. Available from: https://ajeer.meteorpub.com/1/article/view/7